FDA fast tracks epcoritamab for follicular lymphoma

COPENHAGEN - The U.S. Food and Drug Administration (FDA) has granted Priority Review for epcoritamab, a potential new treatment for patients with relapsed or refractory follicular lymphoma, announced Genmab A/S (NASDAQ: NASDAQ:GMAB) and AbbVie (NYSE: NYSE:ABBV). This designation could significantly expedite the therapy\'s approval process, with a target action date set for June 28, 2024....

Read More

Australia\'s Coles denies price gouging, says food inflation is a global problem

By Byron Kaye and Echha Jain SYDNEY (Reuters) - Australia\'s No. 2 supermarket operator Coles Group (OTC:CLEGF) on Tuesday rejected accusations of price gouging as its first-half profit beat analyst forecasts, saying food inflation was a global problem and its margins were steady. Coles and larger rival Woolworths Group, which together account for two-thirds of...

Read More

Bitcoin breaks $57,000 as big buyers circle

SINGAPORE (Reuters) - Cryptocurrency bitcoin hit a two-year high above $57,000 in Asia trade on Tuesday on signs of heavy institutional buying, while smaller rival ether topped $3,200 for the first time in two years. Bitcoin has rallied more than 10% in two sessions, helped by a Monday disclosure from crypto investor and software firm...

Read More

StanChart halts investments by Chinese clients via key offshore program- Reuters

-- Standard Chartered PLC (LON:STAN) suspended new offshore investments by its Chinese clients through a key regulatory program since last week, Reuters reported on Tuesday citing a statement from the lender. The Asia-focused bank told Reuters that it had suspended new investments under the Qualified Domestic Institutional Investor (QDII) programme for “commercial reasons.”  The move comes...

Read More